Anzeige
Mehr »
Lynx Broker
Login
Dienstag, 15.10.2019 Börsentäglich über 12.000 News von 613 internationalen Medien
Investoren zahlen Prämie: Fura Gems schließt Kapitalrunde über 26,8 Mio. CAD ab
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MoBayer opens AI-enabled drug discovery center in UK
MoIn a U-turn, ICER takes more positive view of AbbVie's Rinvoq
MoRoche's MabThera beats incumbent drug in pemphigus vulgaris phase 3
MoFDA approves Lilly's migraine drug Reyvow
MoThe 'blueprint' for MSL success is changing
FrIncreased discount leads NICE to reverse positon on Clovis cancer drug
FrReport finds 'startling' lack of progress of antibiotic R&D agenda
FrGilead builds case for Xeljanz rival filgotinib as it preps US filing
FrAbbVie calls time on Reata alliance, claims $330m payback
FrRare diseases: redefining medical communications
DoUCB gets bigger in rare diseases with $2.1bn purchase of Ra Pharma
DoDaiichi starts challenging Astellas for Japanese AML market
DoNovo Nordisk, bluebird team up to develop haemophilia A therapies
DoShionogi trumpets pneumonia data for new antibiotic cefiderocol
DoCooking up a co-creation feast - beyond vanilla
MiPMLiVE launches its inaugural T40
MiScottish government readies ports to mitigate Brexit supply disruptions
MiGSK forms cell therapy R&D pact with star-studded biotech
MiMerck seeks partner for disease-modifying osteoarthritis drug
MiJ&J hit by $8bn judgment for man claiming breast growth due to Risperdal
08.10.ONEHealth bolstered by Bartlett Davis acquisition
08.10.New hires at Ashfield, Hamell and Springer Healthcare
08.10.Changing direction: adapting to a rapidly-evolving environment
08.10.SMC approves Yescarta and Keytruda, rejects Perjeta
08.10.Novartis bags US okay for Lucentis follow-up Beovu in wet AMD